ClearPoint Neuro, Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: Election of Directors: B. Kristine Johnson

ClearPoint Neuro, Inc.’s own tally for this item (“Elect Director: B. Kristine Johnson”): 9,628,069 for, 178,614 withheld, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following named persons were elected as directors of the Company to serve until the 2027 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 33 asset managers below reported 1,750,555 for, 6,649 withheld.

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

Description as filed by funds: Election of Directors: Joseph M. Burnett

ClearPoint Neuro, Inc.’s own tally for this item (“Elect Director: Joseph M. Burnett”): 9,686,224 for, 120,459 withheld, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following named persons were elected as directors of the Company to serve until the 2027 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 33 asset managers below reported 1,750,555 for, 6,649 withheld.

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

Description as filed by funds: Election of Directors: Linda M. Liau

ClearPoint Neuro, Inc.’s own tally for this item (“Elect Director: Linda M. Liau”): 9,601,872 for, 204,811 withheld, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following named persons were elected as directors of the Company to serve until the 2027 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 33 asset managers below reported 1,748,274 for, 6,806 withheld, 2,123 abstained.

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

Description as filed by funds: Election of Directors: Lynnette C. Fallon

ClearPoint Neuro, Inc.’s own tally for this item (“Elect Director: Lynnette C. Fallon”): 9,625,049 for, 181,634 withheld, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following named persons were elected as directors of the Company to serve until the 2027 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 33 asset managers below reported 1,745,059 for, 10,022 withheld, 2,123 abstained.

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

Description as filed by funds: Election of Directors: Matthew B. Klein

ClearPoint Neuro, Inc.’s own tally for this item (“Elect Director: Matthew B. Klein”): 9,639,952 for, 166,731 withheld, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following named persons were elected as directors of the Company to serve until the 2027 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 33 asset managers below reported 1,750,555 for, 6,649 withheld.

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

Description as filed by funds: Election of Directors: R. John Fletcher

ClearPoint Neuro, Inc.’s own tally for this item (“Elect Director: R. John Fletcher”): 9,676,332 for, 130,351 withheld, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following named persons were elected as directors of the Company to serve until the 2027 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 33 asset managers below reported 1,747,339 for, 9,865 withheld.

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

Description as filed by funds: Election of Directors: Timothy T. Richards

ClearPoint Neuro, Inc.’s own tally for this item (“Elect Director: Timothy T. Richards”): 9,639,577 for, 167,106 withheld, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following named persons were elected as directors of the Company to serve until the 2027 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 33 asset managers below reported 1,746,050 for, 9,031 withheld, 2,122 abstained.

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

Description as filed by funds: Approval of ClearPoint Neuro, Inc.'s Seventh Amended and Restated 2013 Incentive Compensation Plan.

ClearPoint Neuro, Inc.’s own tally for this item (“4. Approval of the Seventh Amended and Restated 2013 Incentive Compensation Plan”): 7,517,634 for, 1,793,261 against — passed, per its Form 8-K filed May 21, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders approved the Company's Seventh Amended and Restated 2013 Incentive Compensation Plan.”
Support: 81% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 33 asset managers below reported 1,692,391 for, 58,163 against, 6,650 abstained.

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

Description as filed by funds: An advisory (non-binding) vote to approve the compensation of ClearPoint Neuro, Inc.'s named executive officers.

ClearPoint Neuro, Inc.’s own tally for this item (“3. Advisory Approval of Executive Compensation”): 8,825,126 for, 442,728 against — passed, per its Form 8-K filed May 21, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3: Advisory Approval of Executive Compensation.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 33 managers: 1,717,542 for, 33,011 against, 6,650 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 98 managers: 2,004,712 for, 158,553 against, 3,793 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratification of the appointment of Cherry Bekaert LLP as ClearPoint Neuro, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026.

ClearPoint Neuro, Inc.’s own tally for this item (“2. The ratification of the appointment of Cherry Bekaert LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026”): 19,296,330 for, 20,086 against — passed, per its Form 8-K filed May 21, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders ratified the selection of Cherry Bekaert LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 33 asset managers below reported 1,750,554 for, 0 against, 6,650 abstained.

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.